Etoposide in combination with intermediate dose cytosine arabinoside (ID ARA C) given with the intention of further myeloablative therapy for the treatment of refractory or recurrent hematological malignancy-Reference-Cited by-同舟云学术

Etoposide in combination with intermediate dose cytosine arabinoside (ID ARA C) given with the intention of further myeloablative therapy for the treatment of refractory or recurrent hematological malignancy

Published:1992-03 Issue:2 Volume:10 Page:87-94
ISSN:0278-0232
Container-title:Hematological Oncology
language:en
Short-container-title:Hematol. Oncol.

Author:

Whelan J. S.,Davis C. L.,Rohatiner A. Z. S.,Leahy M.,Maccallum P. K.,Gupta R. K.,Matthews J.,Norton A. J.,Amess J. A. L.,Lister T. A.

Publisher

Wiley

Subject

Cancer Research,Oncology,Hematology,General Medicine

Reference47 articles.

1. Long-term remission durability and functional status of patients treated for diffuse histiocytic lymphoma with the CHOP regimen.

2. MACOP-B Chemotherapy for the Treatment of Diffuse Large-Cell Lymphoma

3. Identification of Major Prognostic Subgroups of Patients with Large-Cell Lymphoma Treated with m-BACOD or M-BACOD

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunocytoma: A Retrospective Analysis From St Bartholomew's Hospital—1972 to 1996;Journal of Clinical Oncology;1999-09

2. High-dose therapy with autologous haematopoietic support in patients with transformed follicular lymphoma: A study of 27 patients from a single centre;Annals of Oncology;1998-08

3. Intensive chemotherapy for adult acute lymphoblastic leukaemia given with or without granulocyte-macrophage colony stimulating factor;Annals of Hematology;1996-12-16

4. Mediastinal large-cell lymphoma with sclerosis (MLCLS);British Journal of Cancer;1994-03

5. THE CHALLENGE OF ACIJTE LYMPHOBLASTIC LEIIKAEMIA IN ADULTS;British Journal of Haematology;1993-12